{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:11:02Z","timestamp":1790392262200,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T00:00:00Z","timestamp":1389830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00774-013-0560-8","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T13:22:39Z","timestamp":1389792159000},"page":"101-108","source":"Crossref","is-referenced-by-count":24,"title":["Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome"],"prefix":"10.1007","volume":"33","author":[{"given":"Zehra","family":"Berberoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynur","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Fidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Canan","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalcin","family":"Aral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"560_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0015-0282(99)00203-4","volume":"72","author":"C Good","year":"1999","unstructured":"Good C, Tulchinsky M, Mauger D, Demers LM, Legro RS (1999) Bone mineral density and body composition in lean women with polycystic ovary syndrome. Fertil Steril 72:21\u201325","journal-title":"Fertil Steril"},{"key":"560_CR2","first-page":"2821","volume":"82","author":"S Dagogo-Jack","year":"1997","unstructured":"Dagogo-Jack S, al Ali N, Qurttom M (1997) Augmentation of bone mineral density in hirsute women. J Clin Endocrinol Metab 82:2821\u20132825","journal-title":"J Clin Endocrinol Metab"},{"key":"560_CR3","first-page":"779","volume":"75","author":"IR Reid","year":"1992","unstructured":"Reid IR, Plank LD, Evans MC (1992) Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 75:779\u2013782","journal-title":"J Clin Endocrinol Metab"},{"key":"560_CR4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s001980050232","volume":"10","author":"JO Christensen","year":"1999","unstructured":"Christensen JO, Svendsen OL (1999) Bone mineral in pre- and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitus. Osteoporos Int 10:307\u2013311","journal-title":"Osteoporos Int"},{"key":"560_CR5","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1210\/endo.142.9.8402","volume":"142","author":"D Huber","year":"2001","unstructured":"Huber D, Bendixen A, Pathrose P, Srivastava S, Dienger K, Shevde N, Pike J (2001) Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor. Endocrinology 142:3800\u20133808","journal-title":"Endocrinology"},{"key":"560_CR6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1055\/s-2004-826013","volume":"36","author":"Q Chen","year":"2004","unstructured":"Chen Q, Kaji H, Kanatani M, Sugimoto T, Chihara K (2004) Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells. Horm Metab Res 36:674\u2013678","journal-title":"Horm Metab Res"},{"key":"560_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000057358","volume":"24","author":"AB Roberts","year":"1998","unstructured":"Roberts AB (1998) Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24:111\u2013119","journal-title":"Miner Electrolyte Metab"},{"key":"560_CR8","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350\u20131358","journal-title":"N Engl J Med"},{"key":"560_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1568008043339901","volume":"4","author":"K Tsuchida","year":"2004","unstructured":"Tsuchida K (2004) Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders. Curr Drug Targets Immune Endocr Metabol Disord 4:157\u2013166. doi: 10.2174\/1568008043339901","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"560_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1757-2215-2-9","volume":"2","author":"M Orisaka","year":"2009","unstructured":"Orisaka M, Tajima K, Tsang BK, Kotsuji F (2009) Oocyte-granulosa-theca cell interactions during preantral follicular development. J Ovarian Res 2:9. doi: 10.1186\/1757-2215-2-9","journal-title":"J Ovarian Res"},{"key":"560_CR11","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1210\/en.2008-1536","volume":"150","author":"M Orisaka","year":"2009","unstructured":"Orisaka M, Jiang JY, Orisaka S, Kotsuji F, Tsang BK (2009) Growth differentiation factor 9 promotes rat preantral follicle growth by up-regulating follicular androgen biosynthesis. Endocrinology 150:2740\u20132748. doi: 10.1210\/en.2008-1536","journal-title":"Endocrinology"},{"key":"560_CR12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1210\/jcem.87.3.8316","volume":"87","author":"FL Teixeira Filho","year":"2002","unstructured":"Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, Shimasaki S, Erickson GF (2002) Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab 87:1337\u20131344","journal-title":"J Clin Endocrinol Metab"},{"key":"560_CR13","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/endo.139.5.6014","volume":"139","author":"SL Fitzpatrick","year":"1998","unstructured":"Fitzpatrick SL, Sindoni DM, Shughrue PJ, Lane MV, Merchenthaler IJ, Frail DE (1998) Expression of growth differentiation factor-9 messenger ribonucleic acid in ovarian and nonovarian rodent and human tissues. Endocrinology 139:2571\u20132578","journal-title":"Endocrinology"},{"key":"560_CR14","unstructured":"Bowser JL, Srikanthan S, Hendry WJ, May JV (2006) Expression of growth differentiation factor-9 in the developing ovary and in nonovarian tissues. In: Eichhorn DM, Kovar S (eds) Proceedings: 2nd annual symposium on graduate research and scholarly projects. Wichita State University, Wichita, pp 66\u201367"},{"key":"560_CR15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/eurheartj\/ehn600","volume":"30","author":"SQ Khan","year":"2009","unstructured":"Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL (2009) Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J 30:1057\u20131065. doi: 10.1093\/eurheartj\/ehp129","journal-title":"Eur Heart J"},{"key":"560_CR16","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jacc.2007.04.091","volume":"50","author":"T Kempf","year":"2007","unstructured":"Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC (2007) Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50:1054\u20131060","journal-title":"J Am Coll Cardiol"},{"key":"560_CR17","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0140-6736(02)09093-1","volume":"359","author":"DA Brown","year":"2002","unstructured":"Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Liu T, Ridker PM (2002) Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 359:2159\u20132163","journal-title":"Lancet"},{"key":"560_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1373\/clinchem.2010.153726","volume":"57","author":"G Vila","year":"2011","unstructured":"Vila G, Riedl M, Anderwald C, Resl M, Handisurya A, Clodi M, Prager G, Ludvik B, Krebs M, Luger A (2011) The relationship between \u0131nsulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Clin Chem 57:309\u2013316. doi: 10.1373\/clinchem.2010.153726","journal-title":"Clin Chem"},{"key":"560_CR19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/EJE-09-0417","volume":"161","author":"I Dost\u00e1lov\u00e1","year":"2009","unstructured":"Dost\u00e1lov\u00e1 I, Roub\u00edcek T, B\u00e1rtlov\u00e1 M, Mr\u00e1z M, Lacinov\u00e1 Z, Haluz\u00edkov\u00e1 D, Kav\u00e1lkov\u00e1 P, Matoulek M, Kasalicky M, Haluz\u00edk M (2009) Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur J Endocrinol 161:397\u2013404","journal-title":"Eur J Endocrinol"},{"key":"560_CR20","doi-asserted-by":"crossref","first-page":"13760","DOI":"10.1074\/jbc.273.22.13760","volume":"273","author":"VM Paralkar","year":"1998","unstructured":"Paralkar VM, Vail AL, Grasser WA, Brown TA, Xu H, Vukicevic S, Ke HZ, Qi H, Owen TA, Thompson DD (1998) Cloning and characterization of a novel member of the transforming growth factor beta\/bone morphogenic protein family. J Biol Chem 273:13760\u201313767","journal-title":"J Biol Chem"},{"key":"560_CR21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/pros.10365","volume":"59","author":"Y Kakehi","year":"2004","unstructured":"Kakehi Y, Segawa T, Wu XX, Kulkarni P, Dhir R, Getzenberg RH (2004) Down-regulation of macrophage inhibitory cytokine-1\/prostate derived factor in benign prostatic hyperplasia. Prostate 59:351\u2013356","journal-title":"Prostate"},{"key":"560_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diff.2009.07.008","volume":"78","author":"P Vanhara","year":"2009","unstructured":"Vanhara P, Lincov\u00e1 E, Kozub\u00edk A, Jurdic P, Soucek K, Smarda J (2009) Growth\/differentiation factor-15 inhibits differentiation into osteoclasts\u2014a novel factor involved in control of osteoclast differentiation. Differentiation 78:213\u2013222. doi: 10.1016\/j.diff.2009.07.008","journal-title":"Differentiation"},{"key":"560_CR23","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325. doi: 10.1016\/j.fertnstert.2003","journal-title":"Fertil Steril"},{"key":"560_CR24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"560_CR25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1095\/biolreprod.104.028852","volume":"71","author":"RB Gilchrist","year":"2004","unstructured":"Gilchrist RB, Ritter LJ, Cranfield M, Jeffery LA, Amato F, Scott SJ, Myllymaa S, Kaivo-Oja N, Lankinen H, Mottershead DG, Groome NP, Ritvos O (2004) Immunoneutralization of growth differentiation factor 9 reveals it partially accounts for mouse oocyte mitogenic activity. Biol Reprod 71:732\u2013739","journal-title":"Biol Reprod"},{"key":"560_CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1095\/biolreprod.109.083311","volume":"83","author":"F S\u00e1nchez","year":"2010","unstructured":"S\u00e1nchez F, Adriaenssens T, Romero S, Smitz J (2010) Different follicle-stimulating hormone exposure regimens during antral follicle growth alter gene expression in the cumulus-oocyte complex in mice. Biol Reprod 83:514\u2013524. doi: 10.1095\/biolreprod.109.083311","journal-title":"Biol Reprod"},{"key":"560_CR27","first-page":"2849","volume":"87","author":"N Yamamoto","year":"2002","unstructured":"Yamamoto N, Christenson LK, McAllister JM, Strauss JF 3rd (2002) Growth differentiation factor-9 inhibits 3\u20325\u2032-adenosine monophosphate-stimulated steroidogenesis in human granulosa and theca cells. J Clin Endocrinol Metab 87:2849\u20132856. doi: 10.1210\/jc.87.6.2849","journal-title":"J Clin Endocrinol Metab"},{"key":"560_CR28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.fertnstert.2009.03.014","volume":"94","author":"SY Zhao","year":"2010","unstructured":"Zhao SY, Qiao J, Chen YJ, Liu P, Li J, Yan J (2010) Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary syndrome. Fertil Steril 94:261\u2013267. doi: 10.1016\/j.fertnstert.2009.03.014","journal-title":"Fertil Steril"},{"key":"560_CR29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.rbmo.2010.04.013","volume":"21","author":"B Wang","year":"2010","unstructured":"Wang B, Zhou S, Wang J, Liu J, Ni F, Yan J, Mu Y, Cao Y, Ma X (2010) Identification of novel missense mutations of GDF9 in Chinese women with polycystic ovary syndrome. Reprod Biomed Online 21:344\u2013348. doi: 10.1016\/j.rbmo.2010.04.013","journal-title":"Reprod Biomed Online"},{"key":"560_CR30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jsgi.2005.11.005","volume":"13","author":"S Chakrabarty","year":"2006","unstructured":"Chakrabarty S, Miller BT, Collins TJ, Nagamani M (2006) Ovarian dysfunction in peripubertal hyperinsulinemia. J Soc Gynecol Investig 13:122\u2013129","journal-title":"J Soc Gynecol Investig"},{"key":"560_CR31","first-page":"131","volume":"9","author":"SA McGrath","year":"1995","unstructured":"McGrath SA, Esquela AF, Lee SJ (1995) Oocyte-specific expression of growth\/differentiation factor-9. Mol Endocrinol 9:131\u2013136","journal-title":"Mol Endocrinol"},{"key":"560_CR32","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/jbmr.1538","volume":"27","author":"E Hinoi","year":"2012","unstructured":"Hinoi E, Ochi H, Takarada T, Nakatani E, Iezaki T, Nakajima H, Fujita H, Takahata Y, Hidano S, Kobayashi T, Takeda S, Yoneda Y (2012) Positive regulation of osteoclastic differentiation by growth differentiation factor 15 upregulated in osteocytic cells under hypoxia. J Bone Miner Res 27:938\u2013949. doi: 10.1002\/jbmr.1538","journal-title":"J Bone Miner Res"},{"key":"560_CR33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/pros.20913","volume":"69","author":"S Wakchoure","year":"2009","unstructured":"Wakchoure S, Swain TM, Hentunen TA, Bauskin AR, Brown DA, Breit SN, Vuopala KS, Harris KW, Selander KS (2009) Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss. Prostate 69:652\u2013661. doi: 10.1002\/pros.20913","journal-title":"Prostate"},{"key":"560_CR34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1530\/EJE-12-0466","volume":"167","author":"T Kempf","year":"2012","unstructured":"Kempf T, Guba-Quint A, Torgerson J, Magnone MC, Haefliger C, Bobadilla M, Wollert KC (2012) Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur J Endocrinol 167:671\u2013678. doi: 10.1530\/EJE-12-0466","journal-title":"Eur J Endocrinol"},{"key":"560_CR35","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456\u2013469","journal-title":"Cell"},{"key":"560_CR36","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","volume":"16","author":"RJ Norman","year":"2001","unstructured":"Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ (2001) Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 16:1995\u20131998","journal-title":"Hum Reprod"},{"key":"560_CR37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(16)54837-7","volume":"57","author":"C Carlo Di","year":"1992","unstructured":"Di Carlo C, Shoham Z, MacDougall J, Patel A, Hall ML, Jacobs HS (1992) Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea. Fertil Steril 57:314\u2013319","journal-title":"Fertil Steril"},{"key":"560_CR38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s007740170029","volume":"19","author":"O Yuksel","year":"2001","unstructured":"Yuksel O, Dokmetas HS, Topcu S, Erselcan T, Sencan M (2001) Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome. J Bone Miner Metab 19:257\u2013262","journal-title":"J Bone Miner Metab"},{"key":"560_CR39","unstructured":"McCleary L (2008) Bone mineral density in women with polycystic ovary syndrome. Master\u2019s thesis, University of Pittsburgh (unpublished)"},{"key":"560_CR40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2265.1998.3691182.x","volume":"48","author":"S Adami","year":"1998","unstructured":"Adami S, Zamberlan N, Castello R, Tosi F, Gatti D, Moghetti P (1998) Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women. Clin Endocrinol (Oxf) 48:169\u2013173","journal-title":"Clin Endocrinol (Oxf)"},{"key":"560_CR41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2265.2012.04378.x","volume":"77","author":"J Schmidt","year":"2012","unstructured":"Schmidt J, Dahlgren E, Br\u00e4nnstr\u00f6m M, Landin-Wilhelmsen K (2012) Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome\u2014a long-term follow-up study. Clin Endocrinol (Oxf) 77:207\u2013214. doi: 10.1111\/j.1365-2265.2012.04378.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"560_CR42","unstructured":"Johnston C (1993) Osteoporosis. In: Fourth International Symposium on Osteoporosis and the Consensus Development Conference, Hong Kong. Acta Med Port 6:168\u2013170"},{"key":"560_CR43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/EJE-09-0398","volume":"161","author":"E Carmina","year":"2009","unstructured":"Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA (2009) Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol 161:583\u2013589. doi: 10.1530\/EJE-09-0398","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-013-0560-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-013-0560-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-013-0560-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T15:40:02Z","timestamp":1565106002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-013-0560-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["560"],"URL":"https:\/\/doi.org\/10.1007\/s00774-013-0560-8","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}